Tazemetostatfollicular lymphomaepithelioid sarcomatumors
…rest in combining EZH2 inhibitors with adoptive cell therapies. Tazemetostat, a potent EZH2 inhibitor, is FDA-approved for epithelioid sarco…
1articles mentioning drugs
2drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: tazemetostat ×
tazemetostat
This drug is selected. Its supporting articles are shown below.